Latest Funding News

Marimaca Copper Corp. has released a Definitive Feasibility Study for its Marimaca Oxide Deposit in Chile, highlighting a robust 13-year mine life, low capital intensity, and strong financial returns. The study confirms a maiden ore reserve and positions the project as a competitive copper producer with advanced permitting and financing underway.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Felix Group Holdings has launched a $1 million Share Purchase Plan offering shares at a 3.7% discount to support its acquisition of Nexvia Pty Ltd and growth initiatives.

Fortescue Metals Group reported a robust FY25 with record iron ore shipments and strong profits, while advancing its green metal and decarbonisation initiatives. The company also provided solid FY26 guidance amid ongoing exploration and capital discipline.

29Metals has reported a robust turnaround in its half-year results, posting a $35 million net profit and significantly reducing debt, underpinned by operational improvements and insurance proceeds.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Firebrick Pharma has closed a $1.4 million placement to fund expansion of its Nasodine nasal spray in key international markets and advance new product development.

Vulcan Steel is set to acquire Roofing Industries for NZ$88 million, marking a strategic entry into New Zealand’s steel roofing market. The deal is backed by an A$87 million equity raise, positioning Vulcan for growth in building materials.

Vulcan Steel Limited reported a 10.9% revenue decline in FY25 alongside a 24.1% drop in adjusted EBITDA, while announcing a fully underwritten NZ$96 million equity raise to fund the acquisition of Roofing Industries Limited. The deal marks Vulcan’s strategic entry into the New Zealand steel roofing and cladding market with expected earnings accretion and no change to its dividend policy.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.